Literature DB >> 32767323

Reduced long noncoding RNA PGM5-AS1 facilitated proliferation and invasion of colorectal cancer through sponging miR-100-5p.

B Zhou1, F Yi, Y Chen, C-H Li, Y-S Cheng, K Yang.   

Abstract

OBJECTIVE: We aimed at investigating the expression of Long non-coding RNA (LncRNA) PGM5-AS1 and its facilitating effects on proliferation and invasion of colorectal cancer by sponging miR-100-5p. PATIENTS AND METHODS: qRT-PCR was performed to detect the expressions of PGM5-AS1 and SMAD4 in human colorectal cancer tissues and cells. CCK-8 assay was performed to evaluate the SW403 cells proliferation and transwell assay was performed to evaluate the SW403 cells migration. The correlation between miR-100-5p and PGM5-AS1 was detected by statistical analysis. Bioinformatics prediction and Luciferase assay were performed to explore the interaction and binding site of PGM5-AS1 and miR-100-5p, miR-100-5p and SMAD4, respectively.
RESULTS: We found that both PGM5-AS1 and SMAD4 were downregulated in human colorectal cancer tissues and cells. qRT-PCR and CCK-8 assay showed that PGM5-AS1 expression is associated with the proliferation of colorectal cancer cells. Transwell assay showed that PGM5-AS1 regulated the migration ability of colorectal cancer cells. The bioinformatics prediction and Luciferase assay demonstrated that by sponging miR-100-5p, PGM5-AS1 can serve as a molecular sponge to further regulate the expression of SMAD4.
CONCLUSIONS: In this study, we found that lncRNA-PGM5-AS1 was low expressed in human colorectal cancer cells, which could promote tumor proliferation, migration and invasion by serving as a molecular sponge and by modulating the inhibitory effect of miR-100-5p on tumor suppressor gene SMAD4.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32767323     DOI: 10.26355/eurrev_202008_22480

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  Pyroptosis is related to immune infiltration and predictive for survival of colon adenocarcinoma patients.

Authors:  Huiwen Lu; Yimeng Sun; Zirui Zhu; Junqiao Yao; Huimian Xu; Rui Huang; Baojun Huang
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

Review 2.  Portrait of Cancer Stem Cells on Colorectal Cancer: Molecular Biomarkers, Signaling Pathways and miRNAome.

Authors:  Andrea Angius; Antonio Mario Scanu; Caterina Arru; Maria Rosaria Muroni; Vincenzo Rallo; Giulia Deiana; Maria Chiara Ninniri; Ciriaco Carru; Alberto Porcu; Giovanna Pira; Paolo Uva; Paolo Cossu-Rocca; Maria Rosaria De Miglio
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

3.  PGM5-AS1 impairs miR-587-mediated GDF10 inhibition and abrogates progression of prostate cancer.

Authors:  Lei Du; Yongli Gao
Journal:  J Transl Med       Date:  2021-01-06       Impact factor: 5.531

Review 4.  Identification of novel key regulatory lncRNAs in gastric adenocarcinoma.

Authors:  Houri Razavi; Ali Katanforosh
Journal:  BMC Genomics       Date:  2022-05-07       Impact factor: 4.547

Review 5.  Non-coding RNA in cancer.

Authors:  Huiwen Yan; Pengcheng Bu
Journal:  Essays Biochem       Date:  2021-10-27       Impact factor: 8.000

6.  Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer.

Authors:  Minghui Wang; Zhijun Zhang; Deng Pan; Zhigang Xin; Fan Bu; Yue Zhang; Qingwu Tian; Xiaodong Feng
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

7.  Identifying Critical States of Complex Diseases by Single-Sample Jensen-Shannon Divergence.

Authors:  Jinling Yan; Peiluan Li; Rong Gao; Ying Li; Luonan Chen
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

8.  Long non-coding RNA SDCBP2-AS1 delays the progression of ovarian cancer via microRNA-100-5p-targeted EPDR1.

Authors:  Xiu Liu; Chanyuan Liu; Aijun Zhang; Qi Wang; Jiao Ge; Qunying Li; Jinlei Xiao
Journal:  World J Surg Oncol       Date:  2021-07-04       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.